@inproceedings{inproceedings, title = {{Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)}}, url = {{}}, year = {{2024}}, month = {{1}}, author = {{Shah B and Challagulla S and Xu S and Williams R and Ren S and Srivastava T and Gautam R and Yang K}}, volume = {{24}}, journal = {{CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}}, pages = {{S516-S517}}, note = {{Accessed on 2025/07/07}}}